These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 11092663
21. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure. Cleland JG, Nikitin N, McGowan J. Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409 [Abstract] [Full Text] [Related]
22. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT. Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930 [Abstract] [Full Text] [Related]
23. Levosimendan in decompensated heart failure patients: efficacy in a Brazilian cohort. Results of the BELIEF study. Bocchi EA, Vilas-Boas F, Moreira Mda C, Barretto AC, Lage S, Albuquerque D, Baima J, Rassi S, Ribeiro JP, Investigators of BELIEF Study, Heart Failure Working Group of Brazilian Society of Cardiology. Arq Bras Cardiol; 2008 Mar 01; 90(3):182-90. PubMed ID: 18392398 [Abstract] [Full Text] [Related]
24. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone. Nanas JN, Papazoglou P, Tsagalou EP, Ntalianis A, Tsolakis E, Terrovitis JV, Kanakakis J, Nanas SN, Alexopoulos GP, Anastasiou-Nana MI. Am J Cardiol; 2005 Mar 15; 95(6):768-71. PubMed ID: 15757608 [Abstract] [Full Text] [Related]
25. Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure. Parissis JT, Adamopoulos S, Farmakis D, Filippatos G, Paraskevaidis I, Panou F, Iliodromitis E, Kremastinos DT. Heart; 2006 Dec 15; 92(12):1768-72. PubMed ID: 17105880 [Abstract] [Full Text] [Related]
27. Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience. Parle NM, Thomas MD, Dembo L, Best M, Driscoll GO. Heart Lung Circ; 2008 Jun 15; 17(3):206-10. PubMed ID: 18242130 [Abstract] [Full Text] [Related]
34. Effects of levosimendan on heart failure in normotensive patients: does loading dose matter? Palmerini E, Söderberg S, Mondillo S, Favilli R, Lunghetti S. Acute Card Care; 2015 Mar 15; 17(1):14-9. PubMed ID: 25806830 [Abstract] [Full Text] [Related]
35. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure. Oner E, Erturk M, Birant A, Kurtar Mansıroglu A, Akturk IF, Karakurt H, Yalcin AA, Uzun F, Somuncu MU, Yildirim A. Cardiol J; 2015 Mar 15; 22(1):87-93. PubMed ID: 24846511 [Abstract] [Full Text] [Related]
37. Effects of levosimendan/furosemide infusion on plasma brain natriuretic peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients. Feola M, Lombardo E, Taglieri C, Vallauri P, Piccolo S, Valle R. Med Sci Monit; 2011 Feb 25; 17(3):PI7-13. PubMed ID: 21358614 [Abstract] [Full Text] [Related]